- Patofyziologické mechanismy rozvoje ANCA asociovaných vaskulitid2020 | 1. lékařská fakulta
- Analysis of microRNAs in Small Urinary Extracellular Vesicles and Their Potential Roles in Pathogenesis of Renal ANCA-Associated Vasculitis2022 | 1. lékařská fakulta
- ANCA-asociovaná vaskulitida s protilátkami proti proteináze 3 je geneticky odlišná od vaskullitidy s protilátkami proti myeloperoxidáze. Komentář k: NEJM 367,2012,214-2232012 | 1. lékařská fakulta
- Association of a TNFSF13B (BAFF) regulatory region single nucleotide polymorphism with response to rituximab in antineutrophil cytoplasmic antibody-associated vasculitis2017 | 1. lékařská fakulta
- Intracelulární tvorba cytokinů u ANCA -asociované vaskulitidy: nízké hladiny interleukinů-10 v remisi jsou spojeny s vyšším výskytem relapsů během dlouhodobého sledování2009 | 1. lékařská fakulta
- Extrarenal complications of granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA) and their impact on the outcome of the patients2022 | 1. lékařská fakulta
- Výhody stanovení protilátek proti myeloperoxidáze a proteináze-3 chemiluminiscenční metodou u pacientů s ANCA asociovanou vaskulitidou2018 | 1. lékařská fakulta
- Silica and Asbestos Exposure in ANCA-Associated Vasculitis with Pulmonary Involvement2005 | 2. lékařská fakulta
- Characteristics and Outcomes of Granulomatosis With Polyangiitis (Wegener) and Microscopic Polyangiitis Requiring Renal Replacement Therapy: Results From the European Renal Association-European Dialysis and Transplant Association Registry2015 | 1. lékařská fakulta
- Complement Inhibition in ANCA-Associated Vasculitis2022 | 1. lékařská fakulta
- Moderator's view: Should all patients with ANCA-associated vasculitis be primarily treated with rituximab?2015 | 1. lékařská fakulta
- Long-term outcome of patients with ANCA-associated vasculitis treated with plasma exchange: a retrospective, single-centre study2016 | 1. lékařská fakulta
- ANCA-Associated Renal Vasculitis - An Update2013 | 1. lékařská fakulta
- Avacopan in the treatment of ANCA-associated vasculitis2018 | 1. lékařská fakulta
- Serum Hepcidin Is Increased in ANCA-Associated Vasculitis and Correlates With Activity Markers2018 | 1. lékařská fakulta
- Lupus nephritis and ANCA-associated vasculitis: towards precision medicine?2021 | 1. lékařská fakulta
- Management of antineutrophil cytoplasmic antibody-associated vasculitis with glomerulonephritis as proposed by the ACR 2021, EULAR 2022 and KDIGO 2021 guidelines/recommendations2023 | 1. lékařská fakulta
- Exposure to Silica and Risk of ANCA-Associated Vasculitis2006 | 1. lékařská fakulta, Fakulta tělesné výchovy a sportu, 2. lékařská fakulta
- Traditional and Disease-Specific Risk Factors for Cardiovascular Events in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Multinational Retrospective Study2023 | 1. lékařská fakulta
- Renal Transplantation in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Current Perspectives2020 | 1. lékařská fakulta
- Biomarkers of fibrosis, kidney tissue injury and inflammation may predict severity and outcome of renal ANCA - associated vasculitis2023 | 1. lékařská fakulta
- Repeat protocol renal biopsy in ANCA-associated renal vasculitis2014 | 1. lékařská fakulta, 3. lékařská fakulta
- EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis2016 | 1. lékařská fakulta
- Mass spectrometry-based proteomic exploration of the small urinary extracellular vesicles in ANCA-associated vasculitis in comparison with total urine2021 | 1. lékařská fakulta
- Long-term outcome of severe alveolar haemorrhage in ANCA-associated vasculitis: a retrospective cohort study2013 | 1. lékařská fakulta
- Rituximab use in patients with ANCA-associated vasculitis: clinical efficacy and impact on immunological parameters2015 | 1. lékařská fakulta
- Treatment of Severe Renal Disease in ANCA Positive and Negative Small Vessel Vasculitis with Rituximab2015 | 1. lékařská fakulta
- Mycophenolate mofetil versus cyclophosphamide for remission induction in ANCA-associated vasculitis: a randomised, non-inferiority trial2019 | 1. lékařská fakulta
- Matrix Metalloproteinases and Their Tissue Inhibitors: an Evaluation of Novel Biomarkers in ANCA-Associated Vasculitis2019 | 1. lékařská fakulta
- Association of venous thromboembolic events with skin, pulmonary and kidney involvement in ANCA-associated vasculitis: a multinational study2021 | 1. lékařská fakulta